Key terms
About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NVO news
Yesterday
11:13am ET
Amgen price target raised to $325 from $315 at BofA
May 02
9:40am ET
Unusually active option classes on open May 2nd
May 02
8:29am ET
Novo Nordisk Q1 Sales and Profit Surge
May 02
7:49am ET
Novo Nordisk reports Q1 EPS DKK 5.68 vs. DKK 4.39 last year
May 02
7:36am ET
Buy Rating Affirmed for Novo Nordisk on Strong Product Performance and Market Position
May 02
6:56am ET
NVO Earnings: Novo Nordisk Drops Despite Hiked Financial Outlook
May 02
6:23am ET
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Sarepta Therapeutics (SRPT) and Acadia Healthcare (ACHC)
May 01
9:47am ET
Novo Nordisk Completes Share Buyback
May 01
6:51am ET
Galderma Seizes Ozempic Face Opportunity
Apr 30
10:13am ET
FTC expands patent listing challenges for drugs
Apr 26
8:57am ET
Novo Nordisk Shares Capital and Voting Rights Update
Apr 25
6:33am ET
Novo Nordisk Updates Corporate Governance Structure
Apr 25
6:28am ET
Novo Nordisk Executes Share Capital Reduction
Apr 24
3:59pm ET
Senate to probe Ozempic’s ‘outrageously’ high prices, FT reports
Apr 22
10:58am ET
Novo Nordisk Launches Massive Share Buyback
Apr 19
6:21pm ET
VGK vs. EZU: Which Is the Better European Stock ETF?
Apr 19
6:17am ET
Influencers are talking up weight loss drugs, but omit side effects, WSJ says
Apr 17
2:25pm ET
Eli Lilly Stock (NYSE:LLY): Hold Off Until the End of the Month
Apr 17
6:59am ET
Novo Nordisk Executives Trade Company Shares
Apr 17
6:58am ET
Novo Nordisk Launches Major Share Buyback
Apr 16
11:10pm ET
LLY, VKTX, or NVO: Which Weight-Loss Drugmaker Could Gain the Best Returns?
Apr 15
1:34pm ET
Novo Nordisk price target raised to DKK 990 from DKK 930 at Morgan Stanley
Apr 12
12:53pm ET
LLY, NVO: Obesity Drugs May Help with Parkinson’s
Apr 12
4:47am ET
Novo Nordisk initiated with an Outperform at BMO Capital
Apr 12
4:25am ET
Buy Rating for Novo Nordisk: Strong Growth Potential Driven by Strategic Partnerships and Innovative Pipeline
Apr 08
11:57am ET
Novo Nordisk Launches Major Share Buyback
Apr 05
12:40pm ET
Viking Therapeutics Stock (NASDAQ:VKTX): Analysts Stay Bullish on 2024’s Top Mid-Cap
Apr 02
8:27am ET
Novo Nordisk Initiates Multi-Billion Share Buyback
Apr 01
1:57pm ET
Novo Nordisk Launches Multi-Billion Share Buyback
Mar 31
6:52pm ET
Omega Therapeutics price target lowered to $7 from $12 at Chardan
Mar 28
10:39am ET
Novo Nordisk Under Fire, Post-Ozempic Study
No recent press releases are available for NVO
NVO Financials
Key terms
Ad Feedback
NVO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NVO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
